Navigation Links
Life Sciences Organizations Choose Oracle to Accelerate and Simplify Clinical Trial Data Collection

    REDWOOD SHORES, Calif., Jan. 21 /PRNewswire-FirstCall/ --

    News Facts

-- Organizations spanning the life sciences industry -- including biopharmaceutical companies, contract research organizations (CROs) and pharmaceutical manufacturers -- are increasingly turning to Oracle(R) Remote Data Capture (RDC) 4.5.3 ( conduct trials more efficiently and effectively.

    -- Boehringer Ingelheim, Bristol-Myers
Squibb, ICON, LEO Pharma, PPD
and Quintiles Transnational are among a rapidly
growing group of customers using Oracle RDC 4.5.3 to help increase efficiency
in clinical trials data collection, improve data quality and enhance decision

-- Oracle RDC 4.5.3, the latest release of Oracle's best-in-class electronic data capture (EDC) offering, is completely Web-based -- with zero client footprint for the HTML data entry window -- which enables improved global access and performance.

-- This enables life sciences organizations to conduct global clinical studies more cost effectively using paper, electronic data capture, or hybrid methods.

-- The Oracle EDC application helps meet the needs of trial sponsors as well as investigative site personnel by providing a simplified user interface and eliminating site software installation. This helps to increase staff efficiency by allowing investigators to quickly locate patient visits and case report forms (CRFs).

-- Oracle RDC 4.5.3 is integrated with Oracle Clinical (, the industry's leading clinical data management system, and is an integral component of Oracle's extensive suite of clinical trial management applications.

Supporting Quotes

-- "As one of the largest users of Oracle Remote Data Capture 4.5.3, PPD is providing clients with the robustness and flexibility this system offers. We have realized greater efficiencies since implementing Oracle RDC 4.5.3, including reduced study timelines, real-time decision making and ease of use for investigator sites," said Susan Atkinson, Senior Vice President of Biostatistics and Data Management, PPD.

-- "As a global clinical research organization, we manage clinical trials for the world's top 20 pharmaceutical organizations and leading biotechnology companies. Oracle Remote Data Capture 4.5.3 helps us to accelerate the capture of subject data and offers a robust system of edit checks to ensure the data accuracy and integrity essential to effectively managing global mega trials," said Tom O'Leary, Global Head of Data Management, ICON Clinical Research.

-- "Quintiles Transnational is committed to enhancing clinical trial efficiency for its biotech and pharmaceutical clients worldwide. We looked to Oracle Remote Data Capture to help us rationalize and accelerate the clinical trial process through automated data collection, and more rapid data processing and reporting," said Nicolas Schaltenbrand, Senior Director, Global Data Management, Quintiles Transnational.

-- "Life sciences organizations increasingly require software applications that will help them automate and effectively manage the clinical phase from study setup through submission. Oracle's comprehensive suite of applications for clinical development provides an integrated system for managing large volumes of patient data, as well as sophisticated tracking, analysis and reporting capabilities. Today, hundreds of life sciences organizations are harnessing the power of Oracle's clinical solutions to accelerate insights for better health," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit.

Supporting Resources

    -- Oracle Remote Data Capture Data Sheet

-- Oracle Remote Data Capture 4.5.3 News Release (

    -- Oracle in Health Sciences

-- Oracle Announces Creation of Health Sciences Global Business Unit (

About Oracle

Oracle (Nasdaq: ORCL) is the world's largest enterprise software company. For more information about Oracle, please visit our Web site at


Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.


Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
2. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
3. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
4. Gordon, Familant Join Baker Botts as Part of Expanded Life Sciences IP Initiative
5. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
6. Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
8. Aisling Capital Announces Close of US$650M Life Sciences Fund
9. Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar
10. Cell Biosciences Delivers Next Generation System to Stanford University
11. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015  Culprits beware, a University ... professor Jan Halámek, is taking crime scene fingerprint ...   -->   ... --> --> Halámek ... discovered a straightforward concept for identifying whether a ...
(Date:11/30/2015)... ... November 30, 2015 , ... Imagine Exhibitions and ... The Exhibition, opening in March 2016 at Melbourne Museum in Melbourne, Australia. Immediately ... several North American tour dates. The Exhibition is based on Universal Pictures’ Jurassic ...
(Date:11/30/2015)... DIEGO , Nov. 30, 2015  HUYA Bioscience ... China,s pharmaceutical innovations, today announced it ... Drug Development Fund (KDDF) to foster collaboration between KDDF ... development and commercialization of healthcare products for the global ... as an important source of new innovative preclinical and ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... to adding an additional independent director, and the Company ... investigation of allegations in a recent anonymous internet report ... on both initiatives. Linda Powers stated, ...
Breaking Biology Technology:
(Date:11/19/2015)... 2015  Although some 350 companies are actively involved ... few companies, according to Kalorama Information. These include Roche Diagnostics, ... market share of the 6.1 billion-dollar molecular testing market, ... for Molecular Diagnostic s .    ... controlled by one company and only a handful of ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/12/2015)... Nov. 11, 2015   Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
Breaking Biology News(10 mins):